Shineco (NASDAQ: SISI) & BICC: From "Tech On-Chain" to "Global Redeemability"--RWA Ecosystem Takes Off for Long-Term Growth
SISIBEIJING, Aug. 27, 2025 /PRNewswire/ -- Shineco Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a manufacturer of induced pluripotent stem cell (iPSC) technology platforms, has entered into a strategic cooperation agreement with Singapore-based BICC Pte Ltd to jointly promote the...
Shineco Unveils World's First On-Chain Cell Asset Tokenization Platform; Strategic Acquisition Expands Global Blockchain-Biotech Network
SISIBEIJING, Aug. 20, 2025 /PRNewswire/ -- Shineco Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a leading innovator in induced pluripotent stem cell (iPSC) technology, today announced the execution of a "Cellular Asset On-Chaining and Marketing Ecosystem Cooperation Agreement" with...
Shineco Establishes Biological Cell Digital Division to Integrate Biological Cell Assets and Blockchain Technology
SISIBEIJING, Aug. 13, 2025 /PRNewswire/ -- Shineco Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a manufacturer of induced pluripotent stem cell (iPSC) technology platforms, today announced the establishment of a Biological Cell Digital Business Division (the "Division"), and the...
Shineco CEO And CFO Initiate Stock Repurchase Up To $2M
SISIShineco To Raise $13.5M Through Sale Of 18M Common Shares At $0.75 Each To Non-U.S. Investors
SISIShineco's Shineco Life Sciences Group Hong Kong Limited Subsidiary Entered Share Purchase Agreement To Acquire 51% Equity Interest In InfiniClone Limited; Will Pay $19,895,600 In Cash And Issue And Transfer 3,450,000 Shares To Seller
SISIShineco Entered Into A Stock Purchase Agreement With Yi Yang, For 75% Of An Equity Interest In Fuwang; To Acquire 75% Equity Interest For ~$8.8M
SISI